Prestige Consumer Healthcare Q2 Earnings Call Highlights - Yahoo Finance
Prestige Consumer Healthcare reported fiscal second-quarter revenue of $336.3 million, up 22.7% from $274.1 million a year earlier. [[fact:fact-2ngkcwij9]]Excluding foreign currency effects and the Breathe Right and LaCorium acquisitions, revenue declined 1.6%. [[fact:fact-ovcir3ygb]]Adjusted diluted earnings per share rose approximately 6% to $1.13. [[fact:fact-7m3w6qwxk]]Production volatility for Clear Eyes began in late September and continued into October. [[fact:fact-qu8vifkby]]With no safety stock available, the production disruption had an immediate effect on sales. [[fact:fact-pqyqjvyq2]]Prestige expects fiscal 2027 revenue of $1.28 billion to $1.29 billion and adjusted diluted EPS of $4.48 to $4.55. [[fact:fact-rhn92t3ws]]